GSK, Sanofi and CSL Ltd have secured $72 million from the US government to ramp up production of bird flu vaccines, Reuters ...

This article provides a detailed summary of current health news, covering topics such as the plight of displaced Gazan ...

David Boucher, the director of infectious disease preparedness and response at the Administration for Strategic Preparedness and Response, noted the government recently invested $72 million to boost ...

Test results are pending on a worker who had contact with infected herds, California officials report. Meanwhile, federal scientists are studying H5N1 genes in dairy workers in search of mutations ...

Activist investor Starboard Value has taken a roughly $1 billion stake in Pfizer and wants the drugmaker to make changes ...

Six health care workers in the US who were in close contact with a patient known to have bird flu developed mild respiratory ...

The Centers for Disease Control and Prevention should have results later this month that provide more insight into how a ...

The justices will consider the constitutionality of state laws banning gender-affirming care for minors for the first time.

Dr Elias Zerhouni, Sanofi’s R&D President, recently announced that there are 65 new molecular entity projects and vaccine candidates already in clinical development. Of this 65, 17 are already ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...